German Biotech MAB Discovery Inks Two Deals For Its Rabbit-Derived Antibody Technology
This article was originally published in The Pink Sheet Daily
German antibody services company MAB Discovery – forged by former Roche employees – has had its rabbit antibody-derived technology validated by two collaborative agreements with pharma and biotech companies.
You may also be interested in...
Two private equity firms’ agreement to acquire Pharmaceutical Product Development Inc. and take the company private is the latest and largest deal in a recent spate of PE activity among contract research organizations – and perhaps not the last, or even least.
Babiss speaks of the evolving relationships between pharmaceutical firms and CROs, including end-to-end virtualization of R&D.
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.